
Gerald Gauthier
Examiner (ID: 4412, Phone: (571)272-7539 , Office: P/2653 )
| Most Active Art Unit | 2653 |
| Art Unit(s) | 2645, 2692, 2651, 2614, 2653 |
| Total Applications | 2390 |
| Issued Applications | 2033 |
| Pending Applications | 135 |
| Abandoned Applications | 267 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19035615
[patent_doc_number] => 20240085430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Highly Sensitive System and Method for Analysis of Troponin
[patent_app_type] => utility
[patent_app_number] => 18/242804
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242804 | Highly sensitive system and method for analysis of troponin | Sep 5, 2023 | Issued |
Array
(
[id] => 20242120
[patent_doc_number] => 12422432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Methods for assessing mucosal healing in inflammatory bowel disease patients
[patent_app_type] => utility
[patent_app_number] => 18/459908
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 9712
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18459908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/459908 | Methods for assessing mucosal healing in inflammatory bowel disease patients | Aug 31, 2023 | Issued |
Array
(
[id] => 19266705
[patent_doc_number] => 20240210406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => TARGET-BINDING ACTIVATED SPLIT REPORTER SYSTEMS FOR ANALYTE DETECTION AND RELATED COMPONENTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/453745
[patent_app_country] => US
[patent_app_date] => 2023-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18453745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/453745 | Target-binding activated split reporter systems for analyte detection and related components and methods | Aug 21, 2023 | Issued |
Array
(
[id] => 18956499
[patent_doc_number] => 20240044826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => METABOLIC VULNERABILITY ANALYZED BY NMR
[patent_app_type] => utility
[patent_app_number] => 18/366599
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/366599 | METABOLIC VULNERABILITY ANALYZED BY NMR | Aug 6, 2023 | Pending |
Array
(
[id] => 19052253
[patent_doc_number] => 20240094222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/227421
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/227421 | Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof | Jul 27, 2023 | Issued |
Array
(
[id] => 19710491
[patent_doc_number] => 20250020633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => Discovering Active Components in Herbals by Manipulating Common Elements
[patent_app_type] => utility
[patent_app_number] => 18/222447
[patent_app_country] => US
[patent_app_date] => 2023-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222447 | Discovering Active Components in Herbals by Manipulating Common Elements | Jul 15, 2023 | Abandoned |
Array
(
[id] => 18755333
[patent_doc_number] => 20230358766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => SERUM METABOLIC BIOMARKERS FOR DETECTING TUBERCULOSIS AND TUBERCULOSIS DETECTION KIT
[patent_app_type] => utility
[patent_app_number] => 18/350764
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350764 | Serum metabolic biomarkers for detecting tuberculosis and tuberculosis detection kit | Jul 11, 2023 | Issued |
Array
(
[id] => 18895534
[patent_doc_number] => 20240011019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => NUCLEIC ACID-TAGGED COMPOSITIONS AND METHODS FOR MULTIPLEXED PROTEIN-PROTEIN INTERACTION PROFILING
[patent_app_type] => utility
[patent_app_number] => 18/348201
[patent_app_country] => US
[patent_app_date] => 2023-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/348201 | Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling | Jul 5, 2023 | Issued |
Array
(
[id] => 18880505
[patent_doc_number] => 20240003874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => IMMUNOASSAY CONTROLS AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/340791
[patent_app_country] => US
[patent_app_date] => 2023-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18340791
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/340791 | Immunoassay controls and the use thereof | Jun 22, 2023 | Issued |
Array
(
[id] => 19580781
[patent_doc_number] => 12146888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Diagnostic methods for cardiovascular diseases
[patent_app_type] => utility
[patent_app_number] => 18/339066
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 38156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339066 | Diagnostic methods for cardiovascular diseases | Jun 20, 2023 | Issued |
Array
(
[id] => 18667563
[patent_doc_number] => 11774454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Non-invasive analysis of embryo metabolites
[patent_app_type] => utility
[patent_app_number] => 17/001094
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 11108
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001094 | Non-invasive analysis of embryo metabolites | May 11, 2023 | Issued |
Array
(
[id] => 18584073
[patent_doc_number] => 20230266334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHODS OF POLYPEPTIDE IDENTIFICATION AND COMPOSITIONS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/141767
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18141767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/141767 | METHODS OF POLYPEPTIDE IDENTIFICATION AND COMPOSITIONS THEREFOR | Apr 30, 2023 | Abandoned |
Array
(
[id] => 18740948
[patent_doc_number] => 20230349927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => RF biosensor and manufacturing method thereof
[patent_app_type] => utility
[patent_app_number] => 18/307891
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307891 | RF biosensor and manufacturing method thereof | Apr 26, 2023 | Pending |
Array
(
[id] => 18676785
[patent_doc_number] => 20230314415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => POINT OF CARE IMMUNIZATION TESTING SYSTEM - DETECTION METHODS
[patent_app_type] => utility
[patent_app_number] => 18/307192
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307192 | POINT OF CARE IMMUNIZATION TESTING SYSTEM - DETECTION METHODS | Apr 25, 2023 | Pending |
| 18/248505 | PROTEOME ANALYSIS IN PULMONARY HYPERTENSION | Apr 9, 2023 | Pending |
Array
(
[id] => 18498594
[patent_doc_number] => 20230221302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHODS FOR PREDICTING RESPONSE TO TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/187421
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187421 | Methods for predicting response to treatment | Mar 20, 2023 | Issued |
Array
(
[id] => 18831941
[patent_doc_number] => 20230400468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/180745
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180745 | Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereof | Mar 7, 2023 | Pending |
Array
(
[id] => 18755331
[patent_doc_number] => 20230358764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => DIAGNOSTIC METHODS FOR LIVER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/118432
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18118432
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/118432 | DIAGNOSTIC METHODS FOR LIVER DISORDERS | Mar 6, 2023 | Pending |
Array
(
[id] => 18553263
[patent_doc_number] => 20230251275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS
[patent_app_type] => utility
[patent_app_number] => 18/104055
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104055
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104055 | NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS | Jan 30, 2023 | Pending |
Array
(
[id] => 18512550
[patent_doc_number] => 20230228755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHODS OF DIAGNOSING AND TREATING LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 18/102088
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102088
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102088 | Methods of diagnosing and treating lung cancer | Jan 26, 2023 | Issued |